科研製薬(株)の貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証PRM医薬品4521/E00935KAKEN PHARMACEUTICAL CO., LTD.
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2023/04/21日証協無担保0株-100%0株0%1,901株+363.66%
2023/04/21日証協有担保196,701株-47.59%1,792株+12%59,700株-30.82%
2023/04/14日証協無担保49,374株0%0株0%410株-90.26%
2023/04/14日証協有担保375,292株-12.17%1,600株-90.12%86,300株-66.05%
2023/04/07日証協無担保0株0%0株0%4,209株-82.29%
2023/04/07日証協有担保427,298株+1219.92%16,200株-25.98%254,185株+34.77%
2023/03/31日証協無担保0株0%0株0%23,771株+1088.55%
2023/03/31日証協有担保32,373株-75.88%21,886株-33.04%188,601株+204.34%
2023/03/24日証協無担保0株-100%0株0%2,000株+24.92%
2023/03/24日証協有担保134,203株-67.82%32,686株-3.86%61,971株-19.11%
2023/03/17日証協無担保6,000株-9.09%0株0%1,601株+414.79%
2023/03/17日証協有担保417,010株-18.53%34,000株-25.15%76,607株-59.37%
2023/03/10日証協無担保6,600株+1.54%0株0%311株-90%
2023/03/10日証協有担保511,831株+102.38%45,424株+269.3%188,528株+137.03%
2023/03/03日証協無担保6,500株-83.39%0株0%3,110株+55.34%
2023/03/03日証協有担保252,912株+87%12,300株-9.56%79,536株+63.99%
2023/02/24日証協無担保39,126株0%0株0%2,002株-71.81%
2023/02/24日証協有担保135,248株-51.69%13,600株+91.55%48,500株-47.17%
2023/02/17日証協無担保0株-100%0株0%7,102株+29.13%
2023/02/17日証協有担保279,973株-1.47%7,100株-68.86%91,800株-11.7%
2023/02/10日証協無担保4,400株0%0株0%5,500株+103.7%
2023/02/10日証協有担保284,161株+633.41%22,800株+273.77%103,960株+56.26%
2023/02/03日証協無担保0株0%0株0%2,700株-25%
2023/02/03日証協有担保38,745株-77.02%6,100株-65.54%66,531株+123.06%
2023/01/27日証協無担保0株-100%0株0%3,600株+197.52%
2023/01/27日証協有担保168,600株-10.91%17,700株-68.51%29,826株-45.64%
2023/01/20日証協無担保900株-96.06%0株-100%1,210株-49.71%
2023/01/20日証協有担保189,241株+43.58%56,200株+113.69%54,868株-12.46%
2023/01/13日証協無担保22,840株+4468%100株0%2,406株+26.63%
2023/01/13日証協有担保131,802株+145.79%26,300株+526.19%62,676株+52.16%
2023/01/06日証協無担保500株-83.33%100株0%1,900株0%
2023/01/06日証協有担保53,624株+5.82%4,200株+2.44%41,191株-34.43%
2022/12/30日証協無担保3,000株0%0株0%0株-100%
2022/12/30日証協有担保50,674株-78.69%4,100株-85.3%62,822株-50.43%
2022/12/23日証協無担保0株0%0株0%2,102株-46.1%
2022/12/23日証協有担保237,802株+42.62%27,900株+564.29%126,740株+41.98%
2022/12/16日証協無担保0株-100%0株-100%3,900株+25.77%
2022/12/16日証協有担保166,735株+92.23%4,200株-52.27%89,267株-19.85%

※株式分割は考慮していませんのでご注意ください。

Page Top